Investment highlights

Strong market positions

Technology leadership

Continuous investments in user experience and interoperability

Recurring revenue share: 69%

Sustainable revenue & EBITDA growth with high margins

Strong cashflow profile

Excellent track record in value enhancing M&A

€1.188 bnRevenues in 2023

€265mAdjusted EBITDA

22.3%Adjusted EBITDA margin

Digitization in healthcare accelerates growth

Presentation

February 14, 2025

Final results of voluntary public takeover offer – CVC has secured 21.85% of total share capital and voting rights of CompuGroup Medical

January 22, 2025

CVC exceeds minimum acceptance threshold for voluntary public tender offer for CompuGroup Medical – additional acceptance period expected to commence on 29 January

January 3, 2025

CGM issues joint reasoned statement recommending that shareholders accept CVC's voluntary public takeover offer

To the magazine